Author

A. Zebisch

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. Gerger· 1 shared A. Wölfler· 1 shared B. Ju· 1 shared B. Shaner· 1 shared B. White· 1 shared C. Bock· 1 shared C. E. S. Roberts· 1 shared C. Passegger· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gerger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

miR-424(322) is a molecular switch controlling pro-inflammatory vs anti-inflammatory skin DC subset differentiation by modulating TGF-β signaling

V. Zyulina, K.-K. Yan, B. Ju, C. Passegger, C. Tam-Amersdorfer, Q. Pan, T. Sconocchia, C. Pollack, B. Shaner, A. Zebisch, J. Easton, J. Yu, J. Silva, H. Strobl

This study identifies miR-424(322) as a molecular switch that controls the differentiation of pro-inflammatory monocyte-derived DCs (moDCs) versus anti-inflammatory Langerhans cells (LCs) by modulating TGF-β signaling.

bioRxiv · Sep 7, 2020 · PreprintImmunology

Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma

K. Fan, A. Zebisch, K. Horny, D. Schrama, J. C. Becker

The paper knocks down miR-375 in MCC cell lines and finds no significant changes in viability, morphology, or oncogenic pathways, suggesting miR-375 is not an intracellular oncogene in MCC.

bioRxiv · Feb 18, 2020Cancer Biology

Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection of cancer

P. Ulz, S. Perakis, Q. Zhou, T. Moser, J. Belic, I. Lazzeri, A. Wölfler, A. Zebisch, A. Gerger, G. Pristauz, E. Petru, B. White, C. E. S. Roberts, J. St. John, M. G. Schimek, , M. R. Speicher

This study infers tumor cell-specific transcription factor binding from cell-free DNA to predict tumor subtypes and detect cancer early.

bioRxiv · Mar 31, 2019 · PreprintCancer Biology